Literature DB >> 24190977

N-linked glycosylation enrichment for in-depth cell surface proteomics of diffuse large B-cell lymphoma subtypes.

Sally J Deeb1, Juergen Cox, Marc Schmidt-Supprian, Matthias Mann.   

Abstract

Global analysis of lymphoma genome integrity and transcriptomes tremendously advanced our understanding of their biology. Technological advances in mass spectrometry-based proteomics promise to complete the picture by allowing the global quantification of proteins and their post-translational modifications. Here we use N-glyco FASP, a recently developed mass spectrometric approach using lectin-enrichment, in conjunction with a super-SILAC approach to quantify N-linked glycoproteins in lymphoma cells. From patient-derived diffuse large B-cell lymphoma cell lines, we mapped 2383 glycosites on 1321 protein groups, which were highly enriched for cell membrane proteins. This N-glyco subproteome alone allowed the segregation of the ABC from the GCB subtypes of diffuse large B-cell lymphoma, which before gene expression studies had been considered one disease entity. Encouragingly, many of the glycopeptides driving the segregation belong to proteins previously characterized as segregators in a deep proteome study of these subtypes (S. J. Deeb et al. MCP 2012 PMID 22442255). This conforms to the high correlation that we observed between the expression level of the glycosites and their corresponding proteins. Detailed examination of glycosites and glycoprotein expression levels uncovered, among other interesting findings, enrichment of transcription factor binding motifs, including known NF-kappa-B related ones. Thus, enrichment of a class of post-translationally modified peptides can classify cancer types as well as reveal cancer specific mechanistic changes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24190977      PMCID: PMC3879617          DOI: 10.1074/mcp.M113.033977

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  49 in total

1.  A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma.

Authors:  George Wright; Bruce Tan; Andreas Rosenwald; Elaine H Hurt; Adrian Wiestner; Louis M Staudt
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-04       Impact factor: 11.205

2.  A method for the comprehensive proteomic analysis of membrane proteins.

Authors:  Christine C Wu; Michael J MacCoss; Kathryn E Howell; John R Yates
Journal:  Nat Biotechnol       Date:  2003-04-14       Impact factor: 54.908

Review 3.  Mass spectrometry based glycoproteomics--from a proteomics perspective.

Authors:  Sheng Pan; Ru Chen; Ruedi Aebersold; Teresa A Brentnall
Journal:  Mol Cell Proteomics       Date:  2010-08-24       Impact factor: 5.911

4.  The gp200-MR6 molecule which is functionally associated with the IL-4 receptor modulates B cell phenotype and is a novel member of the human macrophage mannose receptor family.

Authors:  P F McKay; N Imami; M Johns; D A Taylor-Fishwick; L M Sedibane; N F Totty; J J Hsuan; D B Palmer; A J George; B M Foxwell; M A Ritter
Journal:  Eur J Immunol       Date:  1998-12       Impact factor: 5.532

Review 5.  Integrin-associated protein (CD47) and its ligands.

Authors:  E J Brown; W A Frazier
Journal:  Trends Cell Biol       Date:  2001-03       Impact factor: 20.808

6.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

7.  Glycoproteomics and glycomics investigation of membrane N-glycosylproteins from human colon carcinoma cells.

Authors:  Anne-Sophie Vercoutter-Edouart; Marie-Christine Slomianny; Olivia Dekeyzer-Beseme; Jean-François Haeuw; Jean-Claude Michalski
Journal:  Proteomics       Date:  2008-08       Impact factor: 3.984

8.  Mass spectrometry (LC-MS/MS) site-mapping of N-glycosylated membrane proteins for breast cancer biomarkers.

Authors:  Stephen A Whelan; Ming Lu; Jianbo He; Weihong Yan; Romaine E Saxton; Kym F Faull; Julian P Whitelegge; Helena R Chang
Journal:  J Proteome Res       Date:  2009-08       Impact factor: 4.466

9.  Super-SILAC allows classification of diffuse large B-cell lymphoma subtypes by their protein expression profiles.

Authors:  Sally J Deeb; Rochelle C J D'Souza; Jürgen Cox; Marc Schmidt-Supprian; Matthias Mann
Journal:  Mol Cell Proteomics       Date:  2012-03-21       Impact factor: 5.911

10.  Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells.

Authors:  R E Davis; K D Brown; U Siebenlist; L M Staudt
Journal:  J Exp Med       Date:  2001-12-17       Impact factor: 14.307

View more
  34 in total

1.  Plumbagin elicits differential proteomic responses mainly involving cell cycle, apoptosis, autophagy, and epithelial-to-mesenchymal transition pathways in human prostate cancer PC-3 and DU145 cells.

Authors:  Jia-Xuan Qiu; Zhi-Wei Zhou; Zhi-Xu He; Ruan Jin Zhao; Xueji Zhang; Lun Yang; Shu-Feng Zhou; Zong-Fu Mao
Journal:  Drug Des Devel Ther       Date:  2015-01-07       Impact factor: 4.162

2.  A Combined Omics Approach to Generate the Surface Atlas of Human Naive CD4+ T Cells during Early T-Cell Receptor Activation.

Authors:  Anke Graessel; Stefanie M Hauck; Christine von Toerne; Edda Kloppmann; Tatyana Goldberg; Herwig Koppensteiner; Michael Schindler; Bettina Knapp; Linda Krause; Katharina Dietz; Carsten B Schmidt-Weber; Kathrin Suttner
Journal:  Mol Cell Proteomics       Date:  2015-05-19       Impact factor: 5.911

3.  Surface Glycoproteomic Analysis Reveals That Both Unique and Differential Expression of Surface Glycoproteins Determine the Cell Type.

Authors:  Suttipong Suttapitugsakul; Lindsey D Ulmer; Chendi Jiang; Fangxu Sun; Ronghu Wu
Journal:  Anal Chem       Date:  2019-05-03       Impact factor: 6.986

4.  Electron-Transfer/Higher-Energy Collision Dissociation (EThcD)-Enabled Intact Glycopeptide/Glycoproteome Characterization.

Authors:  Qing Yu; Bowen Wang; Zhengwei Chen; Go Urabe; Matthew S Glover; Xudong Shi; Lian-Wang Guo; K Craig Kent; Lingjun Li
Journal:  J Am Soc Mass Spectrom       Date:  2017-07-10       Impact factor: 3.109

5.  Recent advances in mass spectrometry (MS)-based glycoproteomics in complex biological samples.

Authors:  Zhengwei Chen; Junfeng Huang; Lingjun Li
Journal:  Trends Analyt Chem       Date:  2018-10-15       Impact factor: 12.296

6.  N-glycoprotein surfaceomes of four developmentally distinct mouse cell types.

Authors:  Erin M Kropp; Subarna Bhattacharya; Matthew Waas; Sandra L Chuppa; Anna-Katerina Hadjantonakis; Kenneth R Boheler; Rebekah L Gundry
Journal:  Proteomics Clin Appl       Date:  2014-08       Impact factor: 3.494

7.  The proteome signature of the inflammatory breast cancer plasma membrane identifies novel molecular markers of disease.

Authors:  Ivette J Suárez-Arroyo; Yismeilin R Feliz-Mosquea; Juliana Pérez-Laspiur; Rezina Arju; Shah Giashuddin; Gerónimo Maldonado-Martínez; Luis A Cubano; Robert J Schneider; Michelle M Martínez-Montemayor
Journal:  Am J Cancer Res       Date:  2016-08-01       Impact factor: 6.166

8.  Site-specific characterization and quantitation of N-glycopeptides in PKM2 knockout breast cancer cells using DiLeu isobaric tags enabled by electron-transfer/higher-energy collision dissociation (EThcD).

Authors:  Zhengwei Chen; Qing Yu; Ling Hao; Fabao Liu; Jillian Johnson; Zichuan Tian; W John Kao; Wei Xu; Lingjun Li
Journal:  Analyst       Date:  2018-05-29       Impact factor: 4.616

9.  Mapping human N-linked glycoproteins and glycosylation sites using mass spectrometry.

Authors:  Liuyi Dang; Li Jia; Yuan Zhi; Pengfei Li; Ting Zhao; Bojing Zhu; Rongxia Lan; Yingwei Hu; Hui Zhang; Shisheng Sun
Journal:  Trends Analyt Chem       Date:  2019-02-13       Impact factor: 12.296

10.  Defective glycosylation and multisystem abnormalities characterize the primary immunodeficiency XMEN disease.

Authors:  Juan C Ravell; Mami Matsuda-Lennikov; Samuel D Chauvin; Juan Zou; Matthew Biancalana; Sally J Deeb; Susan Price; Helen C Su; Giulia Notarangelo; Ping Jiang; Aaron Morawski; Chrysi Kanellopoulou; Kyle Binder; Ratnadeep Mukherjee; James T Anibal; Brian Sellers; Lixin Zheng; Tingyan He; Alex B George; Stefania Pittaluga; Astin Powers; David E Kleiner; Devika Kapuria; Marc Ghany; Sally Hunsberger; Jeffrey I Cohen; Gulbu Uzel; Jenna Bergerson; Lynne Wolfe; Camilo Toro; William Gahl; Les R Folio; Helen Matthews; Pam Angelus; Ivan K Chinn; Jordan S Orange; Claudia M Trujillo-Vargas; Jose Luis Franco; Julio Orrego-Arango; Sebastian Gutiérrez-Hincapié; Niraj Chandrakant Patel; Kimiyo Raymond; Turkan Patiroglu; Ekrem Unal; Musa Karakukcu; Alexandre Gr Day; Pankaj Mehta; Evan Masutani; Suk S De Ravin; Harry L Malech; Grégoire Altan-Bonnet; V Koneti Rao; Matthias Mann; Michael J Lenardo
Journal:  J Clin Invest       Date:  2020-01-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.